However, we and others showed that tumor-derived CCL5 expression did not significantly promote mammary carcinoma growth (10, 49), but the hematopoietic CCL5 played the major role in BC progression by regulating myeloid cells or macrophages in different subtype of BC (10, 50). The gene discussed is CCL5; the disease is neoplasm.